IL6 and COVID-19: Inconsistent findings have been reported regarding the changes in myeloid subsets1, 12, 17, 18; however, severe COVID‐19 patients seem to have an increased number of inflammatory monocytes, producing higher levels of IL‐6 and GM‐CSF.12, 18